Keytruda:
Recent investigations have exposed a dangerous counterfeit market for Keytruda in India, where hospital-level breaches and high drug prices have led to fakes being sold to desperate patients.Keytruda is the brand name for Pembrolizumab, a revolutionary immunotherapy drug used to treat various advanced and aggressive cancers.Unlike traditional treatments that attack the tumor directly, Keytruda is a checkpoint inhibitor that helps the body’s own immune system identify and destroy cancer cells.It is manufactured by the U.S.-based global pharmaceutical giant Merck & Co. (known as MSD outside the U.S. and Canada).The primary goal of Keytruda is to remove the brakes on the immune system. Specifically, it seeks to prevent cancer cells from hiding from the body’s T-cells, thereby allowing the immune system to launch an effective attack against the tumor.
